Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent Achieves Global ISO Accreditation | Contract Pharma

What are you searching for?

Sign in
Breaking News

Catalent Achieves Global ISO Accreditation

Becomes one of the first CDMOs to receive award

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The British Standards Institute (BSI) has awarded Catalent a global accreditation against the international management standards for environment (ISO14001:2015) and Occupational Safety (OHSAS18001:2007). The accreditation, for Catalent’s global Environment, Health & Safety (EHS) management system is one of the first to be awarded in the pharmaceutical industry to a contract development and manufacturing organization (CDMO), according to the company.
 
BSI’s auditors judged that Catalent’s EHS system demonstrates a high-degree of sophistication and maturity and competes at a world-class performance level with other leading industries and businesses.
 
“Our EHS system drives our core values of injury prevention and environmental sustainability, and is central to supporting customer and patient expectations,” said Mark Incledion, global director, EHS, Catalent. “This accreditation is very much in line with Catalent’s patient-first and corporate responsibility-driven philosophy, while helping us meet our environmental targets and promote a cleaner planet.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics